Charles Bugg: Difference between revisions
Patriarca12 (talk | contribs) No edit summary |
No edit summary |
||
| (4 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
[[Image:Charles Bugg.jpg|right|thumb|Charles Bugg]] | |||
'''Charles E. Bugg Sr''' (born [[June 5]], [[1941]] in Durham, North Carolina) is a biochemist, crystallographer, and cofounder of [[BioCryst|BioCryst Pharmaceuticals]] | |||
Bugg was the son of the orthopedic surgeon in North Carolina. He completed a bachelor of science in chemistry at Duke University in his home town, working during the summer at Chemstrand Research Labs. He then earned his PhD in physical chemistry from Rice University in Houston, Texas in [[1965]], followed by two years of postdoctoral study at the California Institute of Technology in Pasadena. | |||
After graduating, Bugg accepted a job with DuPont's polymer fiber division. The company intervened when he was drafted to serve in the [[Vietnam War]], and he was assigned to a research position at their facility in Kinston, North Carolina. In [[1968]], at the recommendation of Bob Corey at CalTech, he accepted a newly-created faculty position in crystallography at the [[Institute for Dental Research]] at [[UAB]]. He became the director of the [[UAB Center for Macromolecular Crystallography]], as well as an associate director of the [[O'Neal Comprehensive Cancer Center|UAB Comprehensive Cancer Center]], and a professor of biochemistry and molecular genetics. Currently he holds the title of professor emeritus in biochemistry and molecular genetics. In [[1974]] and [[1981]] he completed research fellowships at Oxford University in England. He recruited [[Y. S. Babu]] to come from Oxford to join his research team at UAB. Bugg's team designed numerous protein crystallography experiments conducted by NASA astraunauts, including [[Larry DeLucas]]. Bugg served as president of the President of the American Crystallographic Association in [[1987]] and editor-in-chief of its journal, ''Acta Crystallographica'', from 1987 to [[1996]]. | |||
In [[ | |||
In [[1984]], Bugg co-founded the pharmaceutical research firm BioCryst with [[John Montgomery]] and [[William Spencer III|Bill Spencer]]. He hired Babu as the company's first employee. He served as the company's first CEO, and chaired its scientific advisory board. He retired from UAB and was elected chairman of the BioCryst's board in [[1993]], and served a term as president from [[1995]] to [[1996]]. Bugg retired from BioCryst in [[2007]]. | |||
==References== | ==References== | ||
* [http://secfilings.nasdaq.com/edgar_conv_html%2f2005%2f03%2f16%2f0001206774-05-000364.html#FIS_BUSINESS BioCryst Pharmaceuticals Inc.] corporate spotling at NASDAQ. - Accessed September 21, 2006 | * [http://secfilings.nasdaq.com/edgar_conv_html%2f2005%2f03%2f16%2f0001206774-05-000364.html#FIS_BUSINESS BioCryst Pharmaceuticals Inc.] corporate spotling at NASDAQ. - Accessed September 21, 2006 | ||
* Hubbard, Russell. (September 21, 2006) "BioCryst says CEO will retire in 2007." | * Hubbard, Russell. (September 21, 2006) "BioCryst says CEO will retire in 2007." {{BN}} | ||
* Bugg, Charles E. (Spring 2015) "[https://history.amercrystalassn.org/assets/docs/CharlesBuggMemoir-web1.pdf ACA Living History- Charles E.Bugg]" ''ACA RefleXions'', No. 1, pp. 37–42 | |||
* [ | |||
{{DEFAULTSORT:Bugg, Charles E.}} | |||
[[Category:1941 births]] | |||
[[Category:Living people]] | [[Category:Living people]] | ||
[[Category:UAB scientists | [[Category:Chemists]] | ||
[[Category:UAB professors | [[Category:UAB scientists]] | ||
[[Category:Chief executives | [[Category:UAB professors]] | ||
[[Category:Entrepreneurs]] | |||
[[Category:Chief executives]] | |||
Latest revision as of 17:07, 7 July 2021
Charles E. Bugg Sr (born June 5, 1941 in Durham, North Carolina) is a biochemist, crystallographer, and cofounder of BioCryst Pharmaceuticals
Bugg was the son of the orthopedic surgeon in North Carolina. He completed a bachelor of science in chemistry at Duke University in his home town, working during the summer at Chemstrand Research Labs. He then earned his PhD in physical chemistry from Rice University in Houston, Texas in 1965, followed by two years of postdoctoral study at the California Institute of Technology in Pasadena.
After graduating, Bugg accepted a job with DuPont's polymer fiber division. The company intervened when he was drafted to serve in the Vietnam War, and he was assigned to a research position at their facility in Kinston, North Carolina. In 1968, at the recommendation of Bob Corey at CalTech, he accepted a newly-created faculty position in crystallography at the Institute for Dental Research at UAB. He became the director of the UAB Center for Macromolecular Crystallography, as well as an associate director of the UAB Comprehensive Cancer Center, and a professor of biochemistry and molecular genetics. Currently he holds the title of professor emeritus in biochemistry and molecular genetics. In 1974 and 1981 he completed research fellowships at Oxford University in England. He recruited Y. S. Babu to come from Oxford to join his research team at UAB. Bugg's team designed numerous protein crystallography experiments conducted by NASA astraunauts, including Larry DeLucas. Bugg served as president of the President of the American Crystallographic Association in 1987 and editor-in-chief of its journal, Acta Crystallographica, from 1987 to 1996.
In 1984, Bugg co-founded the pharmaceutical research firm BioCryst with John Montgomery and Bill Spencer. He hired Babu as the company's first employee. He served as the company's first CEO, and chaired its scientific advisory board. He retired from UAB and was elected chairman of the BioCryst's board in 1993, and served a term as president from 1995 to 1996. Bugg retired from BioCryst in 2007.
References
- BioCryst Pharmaceuticals Inc. corporate spotling at NASDAQ. - Accessed September 21, 2006
- Hubbard, Russell. (September 21, 2006) "BioCryst says CEO will retire in 2007." The Birmingham News
- Bugg, Charles E. (Spring 2015) "ACA Living History- Charles E.Bugg" ACA RefleXions, No. 1, pp. 37–42